TRPX
Therapix Biosciences Ltd.
TRPX
TRPX
Delisted
TRPX was delisted on the 1st of July, 2020.
4 hedge funds and large institutions have $333K invested in Therapix Biosciences Ltd. in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
$125K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
$98K |
| 3 |
APA
American Portfolios Advisors
Holbrook,
New York
|
$626 |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$109K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
$0 |
| 3 |
UBS Group
Zurich,
Switzerland
|
$0 |
| 4 |
Barclays
London,
United Kingdom
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Hudson Bay Capital Management
Stamford,
Connecticut
| $125K | +$125K | +40,055 | New |
|
|
2
Morgan Stanley
New York
| $109K | -$45K | -14,422 | -29% |
|
|
CH
3
CVI Holdings
Wilmington,
Delaware
| $98K | +$98K | +31,397 | New |
|
|
APA
4
American Portfolios Advisors
Holbrook,
New York
| $626 | +$626 | +200 | New |
|
|
OAM
5
Oxford Asset Management
Oxford,
United Kingdom
| – | -$35K | -10,709 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$15K | -4,612 | Closed |
|
|
7
Barclays
London,
United Kingdom
| – | -$2K | -681 | Closed |
|